COMP <GO>
TFX vs UNH // RETURN ON INVESTED CAPITAL (ROIC)
Teleflex Incorporated (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: TFX 4
— UNH 10
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: UNH
LAST: $139.77 (-1.15%) • MKT CAP: $5.99B
roic
1.80%
LAST: $406.97 (-0.96%) • MKT CAP: $368.83B
roic
11.47%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TFX VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TFX | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.20% | 88.57% | -32.37 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 1.80% | 11.47% | -9.67 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 40.9x | 16.4x | +24.45 | UNH | /valuation <GO> |
| Free Cash Flow Yield | -18.00% | 6.48% | -24.48 | UNH | /fcf-yield <GO> |
| Operating Margin | 5.90% | 4.82% | +1.08 | TFX | /operating-margins <GO> |
| Net Profit Margin | -45.40% | 3.14% | -48.54 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 17.20% | 6.46% | +10.74 | TFX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.01% | 2.28% | -1.27 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.12 | 3.12 | -1.00 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 70.2 | 59.2 | +11.00 | TFX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 0.33 | +0.65 | TFX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.0x | 17.7x | +9.26 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.99B | $368.83B | -$362.84B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TFX REV | UNH REV | TFX GROSS % | UNH GROSS % | TFX FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.99B | $447.57B | 56.2% | 88.7% | — | $16.07B |
| FY 2024 | $1.70B | $400.28B | 61.0% | 88.3% | — | $20.70B |
| FY 2023 | $1.71B | $371.62B | — | 89.6% | — | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TFX // BETA 0.98
UNH // BETA 0.33